The scleral lens market size was USD 301.84 million in 2023 and is expected to reach USD 712.50 million by 2032 and grow at a CAGR of 10.01% over the forecast period of 2024-2032. This report provide trend analysis focused on key adoption and usage metrics, such as the annual number of scleral lens fittings globally and regionally. It evaluates clinical efficacy through success rates in visual acuity improvement and patient comfort levels. The report highlights innovation trends, including the penetration of topography-guided and 3D-printed scleral lenses. It also includes practitioner statistics, such as the growing number of certified scleral lens fitters worldwide. The reimbursement trends and cost analysis are also studied to understand economic accessibility. In addition, the regulatory data available on the FDA and CE-approved scleral lenses is presented, further improving a comprehensive and statistical overview of the market.
The U.S. held the largest share in the scleral lens market in 2023, and is growing with a market size of USD 100.93 Million. The market is projected to reach USD 244.97 million by 2032, expanding at a CAGR of 10.35% during 2024 to 2032. The dominance of the U.S. in the scleral lens market is driven by a combination of advanced healthcare infrastructure, high innovate vision correction technologies adoption, and growing prevalence of ocular surface disorders. The country has a substantial number of certified ophthalmologists and optometrists, which are trained in specialty lens fittings, further enabling greater access and patient reach.
In addition, the presence of specialty lens laboratories and several major market players in the U.S. is fostering innovation and availability and adoption of custom-designed scleral lenses. The implementation of supportive reimbursement policies from medicare and other private insurers further increase the patient affordability and adoption of scleral lens. Although, surging awareness related to the benefits of scleral lenses to treat complex corneal conditions are leading to higher demand, further reinforcing the dominant market position of the U.S.
Drivers:
One of the most significant drivers for the scleral lens market growth is the surging incidence of corneal irregularities including dry eye syndrome, keratoconus, and post-surgical complications. For instance, as per the National Eye Institute, keratoconus affects around 1 in 2,000 individuals in the U.S., and millions suffer from chronic dry eye conditions. These lenses offer superior comfort and optical correction for conditions including keratoconus and dry eye, as compared with the standard contact lenses. These lenses have the ability to maintain a reservoir of tears and vault over the cornea, which makes them ideal for patients with damaged corneal surfaces or dry eyes. With surging clinical awareness, more ophthalmologists are suggesting their patients to adopt scleral lenses as a primary solution. Additionally, the growing advancements in patient education and fitting technologies are driving the adoption across both emerging and developed healthcare settings, further bolstering the global market growth.
Restraints:
Despite having clinical benefits, these scleral lenses are substantially more expensive than the standard soft contact lenses, which is a major restraint to the market expansion. On average, the cost of a pair of customized scleral lenses is approximately between USD 1,000 to USD 3,000, excluding the follow-up and consultation fees. In several nations, including parts of Asia and Europe, a large number of patient population can barely afford these lenses. Even in the U.S., the patients spend a huge amount on these lenses, even after partial coverage is offered by private insurers and Medicare. This cost restraint especially affects the low- and middle-income groups and limits market penetration in regions having underdeveloped insurance frameworks. The increasing need for trained specialists to perform fittings, further raises the total scleral lens adoption costs, generating a financial hurdle for both providers and patients.
Opportunities:
The growing integration of advanced imaging technologies including optical coherence tomography (OCT), profilometry, and corneal topography has changed the fitting process of the scleral lens, offering new growth opportunities. These tools enable the experts to develop lenses that match the complex curves of the patient’s eye, further enhancing wearability and comfort. Furthermore, the surging emergence of 3D printing in lens manufacturing is providing access to cost-effective production and faster prototyping of ultra-customized lenses. The major companies operating in the market are making heavy investments in the automated lens design software and AI-powered diagnostic systems to streamline fittings. Due to the increasing adoption of technology among optometrists and ophthalmologists, the accessibility and efficiency of scleral lenses are expected to rise globally. This shift in technology also opens doors for greater market penetration in regions, which have previously underserved owing to a lack of customization capabilities and fitting infrastructure.
Challenges:
A high level of expertise is required for fitting scleral lenses requires a high level of expertise as they are largely prescribed for patients having complex corneal medical and geometries needs. Scleral lenses must be carefully designed to vault over the cornea and rest on the sclera without causing any damage and discomfort compared to the standard lenses. Moreover, there is a high shortage of trained eye care professionals globally for scleral lenses.
For instance, as per the Scleral Lens Education Society, only a small number of optometrists have expertise in fitting these lenses, especially in the emerging markets. This shortage further leads to inconsistent patient outcomes and also curbs the ability of providers to boost their offerings. Additionally, the learning curve and investment in diagnostic equipment may discourage smaller clinics from entering the market. Addressing these problems remains a crucial challenge for the sustainable growth of the scleral lens market globally.
By Type
By type, the market is bifurcated into mini-scleral lenses and large-scleral lenses. The mini-scleral lenses held the dominant scleral lens market share of 69% in 2023. The segment’s growth is driven by their optimal balance between comfort, ease of fitting, and oxygen permeability. These lenses particularly range from 15 mm to 18 mm in diameter, which makes them easy to handle and fit compared to the larger scleral lenses, particularly for new clinicians and wearers. These types of lenses offer perfect visual correction and stability while decreasing the lens edge awareness, further improving the overall patient comfort. In addition, the mini-scleral lenses need less fluid to fill the vault, which makes them more convenient for daily use. Their size also enables better tear exchange and decrease hypoxia risk, that is mainly important for patients suffering from compromised corneal health. Due to these advantages, the eye care experts often prefer mini-scleral lenses for a large range of ocular surface diseases and corneal irregularities, further propelling the segment’s expansion in the global market.
By Application
On the basis of application, the market is classified into hospitals, eye-clinic, and others. The eye clinics segment dominated the market in terms of share of around 38% in 2023 owing to their increased focus on advanced contact lens fittings and ocular health. These clinics are specifically equipped with the state-of-the-art diagnostic tools including the slit-lamp biomicroscopes, OCT, and corneal topographers that are necessary for accurately fitting complex lenses, such as scleral lenses. The eye-clinics also have trained ophthalmologists and optometrists possessing the expertise required to recommend appropriate lens solutions and diagnose corneal irregularities. The eye clinics offer continuous and personalized care other than general hospitals, which is crucial for patients requiring follow-ups and multiple fittings for scleral lenses.
Additionally, the surging trust and awareness in the dedicated eye care centers to manage conditions including severe dry eye, keratoconus, and complications related to post-surgery have attracted more number of patients seeking treatment at eye clinics, further aiding the segment’s expansion.
In 2023, North America held the dominant position in the market with a share of around 44%. The region’s dominance is due to its well-established healthcare infrastructure, quick adoption of advanced ophthalmic technologies, and high awareness related to specialty eye care solutions. North America, particularly the U.S., has a large base of certified and skilled eye care professionals fitting complex contact lenses, which are supported by strong networks of academic institution and specialty eye clinics. Additionally, the region’s expansion is also driven by the increasing corneal conditions prevalence, including post-surgical corneal irregularities, keratoconus, and ocular surface diseases, which has further raised the demand for scleral lenses as a preferred corrective solution. Several supportive reimbursement policies from both Medicare and private insurers in the U.S. are also improving the patient’s accessibility to these lenses. Moreover, the presence of leading innovators and manufacturers in North America also drives the ongoing product development and availability, driving the dominant position of North America.
Asia Pacific held a substantial market share owing to its rapidly growing healthcare industry, surging incidence of vision-related disorders, and rising awareness of advanced eye care solutions. Countries, such as South Korea, India, China, and Japan, are experience a surge in corneal diseases including post-LASIK complications, dry eye syndrome, and keratoconus, dry eye syndrome, propelling the demand for specialty lenses, such as scleral lenses. The region is also witnessing an increase in healthcare expenditure and disposable income, allowing more patients to afford premium vision correction options. The growth of Asia Pacific is also augmenting owing to the government initiatives to improve eye care services, along with number of investments by the major market players to build local production and distribution networks, and enhance accessibility. The rising number of trained eye care professionals and the high modern diagnostic tools adoption in the urban eye clinics further contribute to the growing market share in the region.
Art Optical Contact Lens Inc (Ampleye, Custom Stable Elite)
Blanchard Lab (Onefit, Onefit MED)
Bausch Health Companies Inc. (Zenlens, Boston XO)
CooperVision (Procornea Scleral, MyDay Toric)
Acculens (Maxim CV, Comfort XL)
TruForm Optics Inc. (Atlantis Scleral, DigiForm Scleral)
BostonSight (BostonSight SCLERAL, FitConnect)
ABB Optical Group (ABB Scleral, Custom Scleral Lens Program)
Essilor (NovaVision Scleral, Scleralis)
Optact International Ltd. (Senso Scleral, Ultra Scleral)
Valley Contax Inc. (Custom Stable, Custom Stable Elite)
SynergEyes (VS Scleral, UltraHealth FC)
Visionary Optics (Europa Scleral, Elara Scleral)
Scanoptics (Optimum Scleral, Precision Fit)
Advanced Vision Technologies (AVT Scleral, ProVision Scleral)
X-Cel Specialty Contacts (Atlantis Scleral, Flexlens ARC)
AccuLens Specialty Contact Lenses (Maxim Plus, EasyFit Scleral)
LCS Labs (Infinity Scleral, ClearVision Scleral)
EyePrint Prosthetics (EyePrintPRO, EyeFit Scleral)
Innovative Sclerals (ISL Scleral, Clarity Scleral)
In October 2023, Alcon introduced TOTAL30 Multifocal, the world’s first monthly contact lens featuring Water Gradient technology for multifocal users. This innovative lens blends advanced hydration technology with an affordable price point, delivering improved all-day comfort and vision correction.
In February 2023, Visionary Optics launched the Europa Tangent, an advanced scleral lens designed with a three-zone step system to ensure a highly customizable and precise fit.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | USD 301.84 Million |
| Market Size by 2032 | USD712.50 Million |
| CAGR | CAGR of10.01 % From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Type (Mini-Scleral Lenses, Large-Scleral Lenses) • By End-Use (Hospitals, Eye-clinic, Others) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Art Optical Contact Lens Inc, Blanchard Lab, Bausch Health Companies Inc., CooperVision, Acculens, TruForm Optics Inc., BostonSight, ABB Optical Group, Essilor, Optact International Ltd., Valley Contax Inc., SynergEyes, Visionary Optics, Scanoptics, Advanced Vision Technologies, X-Cel Specialty Contacts, AccuLens Specialty Contact Lenses, LCS Labs, EyePrint Prosthetics, Innovative Sclerals |
Ans: The Scleral Lens Market was valued at USD 301.84 Million in 2023.
Ans: The expected CAGR of the global Scleral Lens Market during the forecast period is 10.01%
Ans: Eye-clinic Products will grow rapidly in the Scleral Lens Market from 2024-2032.
Ans: The rising prevalence of corneal disorders and ocular surface diseases drives the demand for scleral lens market growth.
Ans: North America led the Scleral Lens Market in the region with the highest revenue share in 2023.
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.2 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Adoption & Usage Statistics
5.2 Clinical Outcomes & Efficacy Data
5.3 Technology & Innovation Metrics
5.4 Regulatory Statistics
6. Competitive Landscape
6.1 List of Major Companies By Region
6.2 Market Share Analysis By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion Plans and New Product Launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Scleral Lens Market Segmentation By Type
7.1 Chapter Overview
7.2 Mini-Scleral Lenses
7.2.1 Mini-Scleral Lenses Trend Analysis (2020-2032)
7.2.2 Mini-Scleral Lenses Market Size Estimates and Forecasts to 2032 (USD Million)
7.3 Large-Scleral Lenses
7.3.1 Large-Scleral Lenses Market Trends Analysis (2020-2032)
7.3.2 Large-Scleral Lenses Market Size Estimates and Forecasts to 2032 (USD Million)
8. Scleral Lens Market Segmentation By End-Use
8.1 Chapter Overview
8.2 Hospitals
8.2.1 Hospitals Market Trends Analysis (2020-2032)
8.2.2 Hospitals Market Size Estimates and Forecasts to 2032 (USD Million)
8.3 Eye-clinic
8.3.1 Eye-clinic Market Trends Analysis (2020-2032)
8.3.2 Eye-clinic Market Size Estimates and Forecasts to 2032 (USD Million)
8.4 Others
8.4.1 Others Market Trends Analysis (2020-2032)
8.4.2 Others Market Size Estimates and Forecasts to 2032 (USD Million)
9. Regional Analysis
9.1 Chapter Overview
9.2 North America
9.2.1 Trends Analysis
9.2.2 North America Scleral Lens Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
9.2.3 North America Scleral Lens Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.2.4 North America Scleral Lens Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.2.5 USA
9.2.5.1 USA Scleral Lens Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.2.5.2 USA Scleral Lens Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.2.6 Canada
9.2.6.1 Canada Scleral Lens Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.2.6.2 Canada Scleral Lens Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.2.7 Mexico
9.2.7.1 Mexico Scleral Lens Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.2.7.2 Mexico Scleral Lens Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.3 Europe
9.3.1 Eastern Europe
9.3.1.1 Trends Analysis
9.3.1.2 Eastern Europe Scleral Lens Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
9.3.1.3 Eastern Europe Scleral Lens Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.3.1.4 Eastern Europe Scleral Lens Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.3.1.5 Poland
9.3.1.5.1 Poland Scleral Lens Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.3.1.5.2 Poland Scleral Lens Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.3.1.6 Romania
9.3.1.6.1 Romania Scleral Lens Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.3.1.6.2 Romania Scleral Lens Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.3.1.7 Hungary
9.3.1.7.1 Hungary Scleral Lens Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.3.1.7.2 Hungary Scleral Lens Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.3.1.8 Turkey
9.3.1.8.1 Turkey Scleral Lens Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.3.1.8.2 Turkey Scleral Lens Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.3.1.9 Rest of Eastern Europe
9.3.1.9.1 Rest of Eastern Europe Scleral Lens Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.3.1.9.2 Rest of Eastern Europe Scleral Lens Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.3.2 Western Europe
9.3.2.1 Trends Analysis
9.3.2.2 Western Europe Scleral Lens Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
9.3.2.3 Western Europe Scleral Lens Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.3.2.4 Western Europe Scleral Lens Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.3.2.5 Germany
9.3.2.5.1 Germany Scleral Lens Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.3.2.5.2 Germany Scleral Lens Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.3.2.6 France
9.3.2.6.1 France Scleral Lens Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.3.2.6.2 France Scleral Lens Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.3.2.7 UK
9.3.2.7.1 UK Scleral Lens Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.3.2.7.2 UK Scleral Lens Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.3.2.8 Italy
9.3.2.8.1 Italy Scleral Lens Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.3.2.8.2 Italy Scleral Lens Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.3.2.9 Spain
9.3.2.9.1 Spain Scleral Lens Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.3.2.9.2 Spain Scleral Lens Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.3.2.10 Netherlands
9.3.2.10.1 Netherlands Scleral Lens Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.3.2.10.2 Netherlands Scleral Lens Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.3.2.11 Switzerland
9.3.2.11.1 Switzerland Scleral Lens Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.3.2.11.2 Switzerland Scleral Lens Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.3.2.12 Austria
9.3.2.12.1 Austria Scleral Lens Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.3.2.12.2 Austria Scleral Lens Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.3.2.13 Rest of Western Europe
9.3.2.13.1 Rest of Western Europe Scleral Lens Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.3.2.13.2 Rest of Western Europe Scleral Lens Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.4 Asia Pacific
9.4.1 Trends Analysis
9.4.2 Asia Pacific Scleral Lens Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
9.4.3 Asia Pacific Scleral Lens Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.4.4 Asia Pacific Scleral Lens Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.4.5 China
9.4.5.1 China Scleral Lens Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.4.5.2 China Scleral Lens Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.4.6 India
9.4.5.1 India Scleral Lens Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.4.5.2 India Scleral Lens Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.4.5 Japan
9.4.5.1 Japan Scleral Lens Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.4.5.2 Japan Scleral Lens Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.4.6 South Korea
9.4.6.1 South Korea Scleral Lens Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.4.6.2 South Korea Scleral Lens Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.4.7 Vietnam
9.4.7.1 Vietnam Scleral Lens Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.2.7.2 Vietnam Scleral Lens Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.4.8 Singapore
9.4.8.1 Singapore Scleral Lens Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.4.8.2 Singapore Scleral Lens Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.4.9 Australia
9.4.9.1 Australia Scleral Lens Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.4.9.2 Australia Scleral Lens Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.4.10 Rest of Asia Pacific
9.4.10.1 Rest of Asia Pacific Scleral Lens Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.4.10.2 Rest of Asia Pacific Scleral Lens Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.5 Middle East and Africa
9.5.1 Middle East
9.5.1.1 Trends Analysis
9.5.1.2 Middle East Scleral Lens Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
9.5.1.3 Middle East Scleral Lens Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.5.1.4 Middle East Scleral Lens Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.5.1.5 UAE
9.5.1.5.1 UAE Scleral Lens Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.5.1.5.2 UAE Scleral Lens Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.5.1.6 Egypt
9.5.1.6.1 Egypt Scleral Lens Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.5.1.6.2 Egypt Scleral Lens Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.5.1.7 Saudi Arabia
9.5.1.7.1 Saudi Arabia Scleral Lens Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.5.1.7.2 Saudi Arabia Scleral Lens Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.5.1.8 Qatar
9.5.1.8.1 Qatar Scleral Lens Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.5.1.8.2 Qatar Scleral Lens Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.5.1.9 Rest of Middle East
9.5.1.9.1 Rest of Middle East Scleral Lens Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.5.1.9.2 Rest of Middle East Scleral Lens Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.5.2 Africa
9.5.2.1 Trends Analysis
9.5.2.2 Africa Scleral Lens Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
9.5.2.3 Africa Scleral Lens Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.5.2.4 Africa Scleral Lens Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.5.2.5 South Africa
9.5.2.5.1 South Africa Scleral Lens Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.5.2.5.2 South Africa Scleral Lens Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.5.2.6 Nigeria
9.5.2.6.1 Nigeria Scleral Lens Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.5.2.6.2 Nigeria Scleral Lens Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.6 Latin America
9.6.1 Trends Analysis
9.6.2 Latin America Scleral Lens Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
9.6.3 Latin America Scleral Lens Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.6.4 Latin America Scleral Lens Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.6.5 Brazil
9.6.5.1 Brazil Scleral Lens Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.6.5.2 Brazil Scleral Lens Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.6.6 Argentina
9.6.6.1 Argentina Scleral Lens Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.6.6.2 Argentina Scleral Lens Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.6.7 Colombia
9.6.7.1 Colombia Scleral Lens Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.6.7.2 Colombia Scleral Lens Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
9.6.8 Rest of Latin America
9.6.8.1 Rest of Latin America Scleral Lens Market Estimates and Forecasts, By Type (2020-2032) (USD Million)
9.6.8.2 Rest of Latin America Scleral Lens Market Estimates and Forecasts, By End-Use (2020-2032) (USD Million)
10. Company Profiles
10.1 Art Optical Contact Lens Inc
10.1.1 Company Overview
10.1.2 Financial
10.1.3 Product / Services Offered
10.1.4 SWOT Analysis
10.2 Blanchard Lab
10.2.1 Company Overview
10.2.2 Financial
10.2.3 Product/ Services Offered
10.2.4 SWOT Analysis
10.3 Bausch Health Companies Inc.
10.3.1 Company Overview
10.3.2 Financial
10.3.3 Product/ Services Offered
10.3.4 SWOT Analysis
10.4 Cooper Vision
10.4.1 Company Overview
10.4.2 Financial
10.4.3 Product/ Services Offered
10.4.4 SWOT Analysis
10.5 Acculens
10.5.1 Company Overview
10.5.2 Financial
10.5.3 Product/ Services Offered
10.5.4 SWOT Analysis
10.6 TruForm Optics Inc.
10.6.1 Company Overview
10.6.2 Financial
10.6.3 Product/ Services Offered
10.6.4 SWOT Analysis
10.7 BostonSight
10.7.1 Company Overview
10.7.2 Financial
10.7.3 Product/ Services Offered
10.7.4 SWOT Analysis
10.8 ABB Optical Group
10.8.1 Company Overview
10.8.2 Financial
10.8.3 Product/ Services Offered
10.8.4 SWOT Analysis
10.9 Essilor
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Product/ Services Offered
10.9.4 SWOT Analysis
10.10 Optact International Ltd.
10.10.1 Company Overview
10.10.2 Financial
10.10.3 Product/ Services Offered
10.10.4 SWOT Analysis
11. Use Cases and Best Practices
12. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
By Type
Mini-Scleral Lenses
Large-Scleral Lenses
By End-Use
Hospitals
Eye-clinic
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Detailed Volume Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Competitive Product Benchmarking
Geographic Analysis
Additional countries in any of the regions
Customized Data Representation
Detailed analysis and profiling of additional market players
The Medical Device Security Market was valued at USD 6.6 Bn in 2023 and is expected to reach USD 14.2 Bn by 2032, growing at a CAGR of 8.9% from 2024 to 2032.
Medical Writing Market was valued at USD 4.3 billion in 2023 and projected to reach USD 10.5 billion by 2032, growing at 10.45% CAGR from 2024–2032
The Brain Computer Interface Market size was valued at USD 2.23 billion in 2023 and is expected to reach USD 8.36 billion by 2032 and grow at a CAGR of 15.81% over the forecast period of 2024-2032.
The Pharmaceutical Cleaning Validation Market was valued at USD 18.15 billion in 2023 and is expected to reach USD 31.94 billion by 2032, growing at a CAGR of 6.52% from 2024-2032.
The Direct-to-Consumer Genetic Testing Market valued at USD 1.71 billion in 2023, projected to reach USD 7.59 billion by 2032, growing at a CAGR of 17.64%.
The Laser Hair Removal Market Size was valued at USD 1.23 billion in 2023 and is witnessed to reach USD 5.02 billion by 2032 and grow at a CAGR of 17.81% over the forecast period 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2025 All Rights Reserved by SNS Insider Pvt Ltd
